Matches in SemOpenAlex for { <https://semopenalex.org/work/W2007709610> ?p ?o ?g. }
- W2007709610 endingPage "510" @default.
- W2007709610 startingPage "495" @default.
- W2007709610 abstract "Studies of novel centrally acting drugs in healthy volunteers are traditionally concerned with kinetics and tolerability, but useful information may also be obtained from biomarkers of clinical endpoints. This paper provides a systematic overview of CNS-tests used with SSRIs in healthy subjects. A useful biomarker should meet the following requirements: a consistent response across studies and drugs; a clear response of the biomarker to a therapeutic dose; a dose-response relationship; a plausible relationship between biomarker, pharmacology and pathogenesis.These criteria were applied to all individual tests found in studies of selective serotonin reuptake inhibitors (SSRIs), performed in healthy subjects since 1966, identified with a systematic MedLine search. Separate databases were created to evaluate the effects of single or multiple dose SSRI-studies, and for amitriptyline whenever the original report included this antidepressant as a positive control. Doses of the antidepressant were divided into high- and low-dose ranges, relative to a medium range of therapeutic doses. For each test, the drug effects were scored as statistically significant impairment/decrease (-), improvement/increase (+) or no change (=) relative to placebo.56 single dose studies and 22 multiple dose studies were identified, investigating the effects of 13 different SSRIs on 171 variants of neuropsychological tests, which could be clustered into seven neuropsychological domains. Low single doses of SSRIs generally stimulated tests of attention and memory. High doses tended to impair visual/auditory and visuomotor systems and subjective performance, while showing an acceleration in motor function. The most pronounced effects were observed using tests that measure flicker discrimination (improvement at low doses: 75%, medium doses: 40%, high doses: 43% of studies); REM sleep (inconsistent decrease after medium doses, decrease in 83% of studies after high doses); and EEG recordings, predominantly in alpha (decrease in 60% and 43% of studies after low and medium doses, respectively) and in theta activity (increase in 43% and 33% of studies after medium and high doses, respectively). Amitriptyline generally impaired central nervous system (CNS) functions, which increased with doses. Multiple doses caused less pronounced effects on the reported tests. The most responsive tests to amitriptyline appeared to be EEG alpha and theta, and REM sleep duration.SSRIs in healthy subjects appear to cause slight stimulating effects after low doses, which tend to diminish with dose. The most consistent effects were observed with flicker discrimination tests, EEG (alpha and beta bands), REM sleep duration, and subjective effects at higher doses. These effects are small compared with amitriptyline and other CNS-active drugs. Multiple dosing with SSRIs caused even fewer measurable differences from placebo, probably due to adaptive processes. SSRI-effects are best detected with a test battery that is sensitive to general CNS-stimulation, but such tests only comprise a very small portion of the close to 200 different methods that were found in current review." @default.
- W2007709610 created "2016-06-24" @default.
- W2007709610 creator A5004955412 @default.
- W2007709610 creator A5010028133 @default.
- W2007709610 creator A5030730129 @default.
- W2007709610 creator A5085437430 @default.
- W2007709610 date "2005-04-19" @default.
- W2007709610 modified "2023-10-17" @default.
- W2007709610 title "Biomarkers for the effects of selective serotonin reuptake inhibitors (SSRIs) in healthy subjects" @default.
- W2007709610 cites W139679737 @default.
- W2007709610 cites W1593892605 @default.
- W2007709610 cites W1963702566 @default.
- W2007709610 cites W1964290959 @default.
- W2007709610 cites W1966747636 @default.
- W2007709610 cites W1974506402 @default.
- W2007709610 cites W1977554432 @default.
- W2007709610 cites W1978686299 @default.
- W2007709610 cites W1979124919 @default.
- W2007709610 cites W1990883302 @default.
- W2007709610 cites W1993511881 @default.
- W2007709610 cites W1994440801 @default.
- W2007709610 cites W1996764629 @default.
- W2007709610 cites W1997697471 @default.
- W2007709610 cites W2008700075 @default.
- W2007709610 cites W2010374453 @default.
- W2007709610 cites W2010535287 @default.
- W2007709610 cites W2017318750 @default.
- W2007709610 cites W2017438029 @default.
- W2007709610 cites W2020242687 @default.
- W2007709610 cites W2028488418 @default.
- W2007709610 cites W2031134409 @default.
- W2007709610 cites W2033762891 @default.
- W2007709610 cites W2035578288 @default.
- W2007709610 cites W2037188108 @default.
- W2007709610 cites W2041040087 @default.
- W2007709610 cites W2042542409 @default.
- W2007709610 cites W2043718585 @default.
- W2007709610 cites W2044558687 @default.
- W2007709610 cites W2046247411 @default.
- W2007709610 cites W2052683171 @default.
- W2007709610 cites W2054575754 @default.
- W2007709610 cites W2055929822 @default.
- W2007709610 cites W2056312428 @default.
- W2007709610 cites W2060071097 @default.
- W2007709610 cites W2063840650 @default.
- W2007709610 cites W2065532796 @default.
- W2007709610 cites W2067451952 @default.
- W2007709610 cites W2067999453 @default.
- W2007709610 cites W2068073263 @default.
- W2007709610 cites W2068079548 @default.
- W2007709610 cites W2069100239 @default.
- W2007709610 cites W2069203291 @default.
- W2007709610 cites W2070670777 @default.
- W2007709610 cites W2071726260 @default.
- W2007709610 cites W2072667078 @default.
- W2007709610 cites W2072745720 @default.
- W2007709610 cites W2074404162 @default.
- W2007709610 cites W2074544289 @default.
- W2007709610 cites W2075066549 @default.
- W2007709610 cites W2075862832 @default.
- W2007709610 cites W2078959870 @default.
- W2007709610 cites W2080825784 @default.
- W2007709610 cites W2080911984 @default.
- W2007709610 cites W2092537979 @default.
- W2007709610 cites W2096266931 @default.
- W2007709610 cites W2105869026 @default.
- W2007709610 cites W2107876659 @default.
- W2007709610 cites W2110183017 @default.
- W2007709610 cites W2117744574 @default.
- W2007709610 cites W2118568573 @default.
- W2007709610 cites W2121027484 @default.
- W2007709610 cites W2131690429 @default.
- W2007709610 cites W2136339668 @default.
- W2007709610 cites W2156112600 @default.
- W2007709610 cites W2156128976 @default.
- W2007709610 cites W2276952219 @default.
- W2007709610 cites W2396935821 @default.
- W2007709610 cites W2468943027 @default.
- W2007709610 cites W4239322337 @default.
- W2007709610 cites W77213692 @default.
- W2007709610 cites W1977234960 @default.
- W2007709610 doi "https://doi.org/10.1111/j.1365-2125.2005.02342.x" @default.
- W2007709610 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/1884839" @default.
- W2007709610 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/15842547" @default.
- W2007709610 hasPublicationYear "2005" @default.
- W2007709610 type Work @default.
- W2007709610 sameAs 2007709610 @default.
- W2007709610 citedByCount "99" @default.
- W2007709610 countsByYear W20077096102012 @default.
- W2007709610 countsByYear W20077096102013 @default.
- W2007709610 countsByYear W20077096102014 @default.
- W2007709610 countsByYear W20077096102015 @default.
- W2007709610 countsByYear W20077096102016 @default.
- W2007709610 countsByYear W20077096102017 @default.
- W2007709610 countsByYear W20077096102018 @default.
- W2007709610 countsByYear W20077096102019 @default.
- W2007709610 countsByYear W20077096102020 @default.
- W2007709610 countsByYear W20077096102021 @default.